Studies [11] confirmed that antisense oligonucleotide of BCL-2 can effectively reduce the expression of BCL-2 in breast cancer cells, reduced the inhibition caused by the BCL-2 gene in chemotherapy-induced apoptosis, improved the treatment effect. Here, BCL2 is linked to breast carcinoma.